|
CBLL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.135800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.732300E-02 |
| Normal-vs-Stage2 |
6.738000E-01 |
| Normal-vs-Stage3 |
1.258780E-01 |
| Normal-vs-Stage4 |
4.771700E-02 |
| Stage1-vs-Stage2 |
5.102000E-01 |
| Stage1-vs-Stage3 |
1.102630E-03 |
| Stage1-vs-Stage4 |
1.789660E-04 |
| Stage2-vs-Stage3 |
1.941760E-01 |
| Stage2-vs-Stage4 |
1.183620E-01 |
| Stage3-vs-Stage4 |
6.961000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.059400E-01 |
| Normal-vs-AfricanAmerican |
3.514800E-01 |
| Normal-vs-Asian |
3.778200E-01 |
| Caucasian-vs-AfricanAmerican |
1.566780E-01 |
| Caucasian-vs-Asian |
3.990400E-01 |
| AfricanAmerican-vs-Asian |
2.607400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.125000E-01 |
| Normal-vs-Female |
5.316600E-01 |
| Male-vs-Female |
5.563600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.306400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.445600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.458000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.758200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.965600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.974000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.088800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.502000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.853700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.406450E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.239800E-01 |
| Normal-vs-Grade 2 |
3.635700E-02 |
| Normal-vs-Grade 3 |
2.273800E-01 |
| Normal-vs-Grade 4 |
9.683000E-03 |
| Grade 1-vs-Grade 2 |
9.908200E-01 |
| Grade 1-vs-Grade 3 |
1.536580E-01 |
| Grade 1-vs-Grade 4 |
3.591800E-02 |
| Grade 2-vs-Grade 3 |
7.198500E-04 |
| Grade 2-vs-Grade 4 |
3.92860000000272E-05 |
| Grade 3-vs-Grade 4 |
5.918200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.683300E-03 |
| Normal-vs-ccB subtype |
8.641600E-01 |
| ccA subtype-vs-ccB subtype |
1.585600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.243200E-01 |
| Normal-vs-N1 |
7.281400E-01 |
| N0-vs-N1 |
5.273200E-01 |
|
|
